Hepatitis by Mel Krajden

Get full text

Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C by Priscilla C Hsu, Jane A Buxton, Andrew W Tu, Warren D Hill, Amanda Yu, Mel Krajden

Get full text

Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis. by Carole Lunny, Darlene Taylor, Linda Hoang, Tom Wong, Mark Gilbert, Richard Lester, Mel Krajden, Gina Ogilvie

Get full text

Prevalence and Incidence of Hepatitis C Virus in Hemodialysis Patients in British Columbia: Follow-up after a Possible Breach in Hemodialysis Machines by Andrew W Tu, Jane A Buxton, Mandy Whitlock, Ognjenka Djurdjev, Mei Chong, Mel Krajden, Monica Beaulieu, Adeera Levin

Get full text

Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon by Jane D Collier, Paul A Adams, Victor Feinman, Cameron Ghent, Helga Witt-Sullivan, Gerald Minuk, Mel Krajden, Jenny Heathcote

Get full text

Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012. by Jason Grebely, Viviane Dias Lima, Brandon D L Marshall, M-J Milloy, Kora DeBeck, Julio Montaner, Annick Simo, Mel Krajden, Gregory J Dore, Thomas Kerr, Evan Wood

Get full text

Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian... by Julio S G Montaner, Viviane D Lima, P Richard Harrigan, Lillian Lourenço, Benita Yip, Bohdan Nosyk, Evan Wood, Thomas Kerr, Kate Shannon, David Moore, Robert S Hogg, Rolando Barrios, Mark Gilbert, Mel Krajden, Reka Gustafson, Patricia Daly, Perry Kendall

Get full text

Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia by James Wilton, Mel Krajden, Dahn Jeong, Stanley Wong, Amanda Yu, Mawuena Binka, Sofia Bartlett, Margo Pearce, Hasina Samji, Naveed Zafar Janjua, Zahid Ahmad Butt, Younathan Abdia, Mohammad Ehsanul Karim, Prince Asumadu Adu, Emilia Clementi, Héctor Alexander Velásquez García

Get full text

The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era by Sonya A MacParland, Marc Bilodeau, Jason Grebely, Julie Bruneau, Curtis Cooper, Marina Klein, Selena M Sagan, Norma Choucha, Louise Balfour, Frank Bialystok, Mel Krajden, Jennifer Raven, Eve Roberts, Rodney Russell, Michael Houghton, D Lorne Tyrrell, Jordan J Feld

Get full text

Personalized risk assessment of drug-related harm is associated with health outcomes. by Andrea A Jones, Fidel Vila-Rodriguez, William J Panenka, Olga Leonova, Verena Strehlau, Donna J Lang, Allen E Thornton, Hubert Wong, Alasdair M Barr, Ric M Procyshyn, Geoffrey N Smith, Tari Buchanan, Mel Krajden, Michael Krausz, Julio S Montaner, G William Macewan, David J Nutt, William G Honer

Get full text

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants by Jimena Pérez-Vargas, Liam J. Worrall, Andrea D. Olmstead, Anh-Tien Ton, Jaeyong Lee, Ivan Villanueva, Connor A. H. Thompson, Svenja Dudek, Siobhan Ennis, Jason R. Smith, Tirosh Shapira, Joshua De Guzman, Shutong Gang, Fuqiang Ban, Marija Vuckovic, Michael Bielecki, Suzana Kovacic, Calem Kenward, Christopher Yee Hong, Danielle G. Gordon, Paul N. Levett, Mel Krajden, Richard Leduc, Pierre-Luc Boudreault, Masahiro Niikura, Mark Paetzel, Robert N. Young, Artem Cherkasov, Natalie C. J. Strynadka, François Jean

Get full text